{"id":282646,"date":"2026-10-01T10:02:59","date_gmt":"2026-10-01T04:32:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=282646"},"modified":"2026-10-01T10:02:59","modified_gmt":"2026-10-01T04:32:59","slug":"why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/","title":{"rendered":"SYMBIOTEC PHARMALAB LTD (SYMBIOTEC): SYMBIOTEC 52 Week High Streak: Consecutive High Analysis"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 1,186.95, up 0.93% from the previous close. Market cap was Rs 7,353.15 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><strong>SYMBIOTEC 52 Week High Streak<\/strong> has now held for its second straight session, with the stock trading within 2% of its 52-week high across the streak and moving up 3.72% over that span. The latest price action keeps the stock near its one-year peak, while the latest Univest figures confirm the pattern but do not establish a company-specific catalyst for the continued move. For readers tracking <strong>SYMBIOTEC 52 Week High Streak<\/strong>, the main point is the repetition, not just the day\u2019s move.<\/p>\n<p style=\"margin-top:0!important;\">At 01 October 2026 at 9:52 AM IST, <strong>SYMBIOTEC Share Price Today<\/strong> stood at Rs 1186.95, above the previous close of Rs 1176.05 after opening at Rs 1197.8 and moving between Rs 1159.85 and Rs 1222. The company\u2019s market capitalisation stands at Rs 7353.15 crore, which places the <strong>SYMBIOTEC Share Price<\/strong> near its yearly high without turning this into a new all-time high claim. For investors, the repeated-high pattern is more informative than a one-session move because it shows the stock is staying close to its peak.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#SYMBIOTEC_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"SYMBIOTEC 52 Week High Streak: Consecutive High Analysis\">SYMBIOTEC 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\" title=\"SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Why_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_May_Be_Moving_Today\" title=\"Why SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) May Be Moving Today\">Why SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) May Be Moving Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC\" title=\"Why Investors Are Watching SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)\">Why Investors Are Watching SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#About_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC\" title=\"About SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)\">About SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#What_does_the_SYMBIOTEC_52_Week_High_Streak_mean\" title=\"What does the SYMBIOTEC 52 Week High Streak mean?\">What does the SYMBIOTEC 52 Week High Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#How_many_sessions_has_SYMBIOTEC_traded_near_its_52-week_high\" title=\"How many sessions has SYMBIOTEC traded near its 52-week high?\">How many sessions has SYMBIOTEC traded near its 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#What_is_the_cumulative_move_in_the_SYMBIOTEC_52_Week_High_Streak\" title=\"What is the cumulative move in the SYMBIOTEC 52 Week High Streak?\">What is the cumulative move in the SYMBIOTEC 52 Week High Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Is_SYMBIOTEC_at_a_new_all-time_high\" title=\"Is SYMBIOTEC at a new all-time high?\">Is SYMBIOTEC at a new all-time high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#What_are_the_latest_SYMBIOTEC_Share_Price_Today_levels\" title=\"What are the latest SYMBIOTEC Share Price Today levels?\">What are the latest SYMBIOTEC Share Price Today levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#How_does_SYMBIOTEC_compare_with_peers_on_valuation\" title=\"How does SYMBIOTEC compare with peers on valuation?\">How does SYMBIOTEC compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#What_fundamental_metrics_matter_most_for_SYMBIOTEC_Stock_Analysis\" title=\"What fundamental metrics matter most for SYMBIOTEC Stock Analysis?\">What fundamental metrics matter most for SYMBIOTEC Stock Analysis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#What_should_investors_monitor_next_in_SYMBIOTEC_Stock_News\" title=\"What should investors monitor next in SYMBIOTEC Stock News?\">What should investors monitor next in SYMBIOTEC Stock News?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-symbiotec-pharmalab-ltd-share-near-52-week-consecutive-high-2026\/#Track_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Share_Price_on_Univest\" title=\"Track SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price on Univest\">Track SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>SYMBIOTEC 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,186.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,176.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 10.9 (+0.93%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,197.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,222<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,159.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,353.15 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) traded at Rs 1,186.95 versus the previous close of Rs 1,176.05, a rise of 0.93%. The stock opened at Rs 1,197.8, reached a high of Rs 1,222 and touched a low of Rs 1,159.85.<\/p>\n<p><strong>SYMBIOTEC Share Price Today<\/strong> was Rs 1186.95, up Rs 10.9 or 0.93% from the previous close. The stock opened at Rs 1197.8, touched a high of Rs 1222 and a low of Rs 1159.85, and was trading within that range as of 01 October 2026 at 9:52 AM IST. The move keeps <strong>SYMBIOTEC Share Price<\/strong> close to the 52-week high zone and continues the visible pattern behind the <strong>SYMBIOTEC 52 Week High Streak<\/strong>. The company\u2019s market capitalisation at Rs 7353.15 crore also gives context to the move, showing that the stock is trading at a meaningful equity value level while remaining in a repeated-near-high phase. For readers following <strong>SYMBIOTEC Stock News<\/strong>, the point here is the persistence of the price behaviour rather than a single sharp jump. That is why the current <strong>SYMBIOTEC Stock Performance<\/strong> deserves attention in the broader <strong>SYMBIOTEC Stock Analysis<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>SYMBIOTEC 52 Week High Streak<\/strong> now reflects a second straight session of trading near the one-year peak, and that repeated pattern is the key signal from the market data. The current streak has delivered a cumulative move of 3.72%, which helps frame the move across multiple sessions rather than a single day. The latest setup also shows that the stock is still trading near a one-year high rather than at a new record high, so this remains a 52-week high event and not an all-time high event. That distinction matters for readers searching for <strong>SYMBIOTEC New One Year High<\/strong> or <strong>SYMBIOTEC Back To Back 52 Week Highs<\/strong>. The pattern confirms durability near the top of the range, but the figures alone do not establish a fresh company-specific trigger beyond the news item noted above. In that sense, the <strong>SYMBIOTEC 52 Week High Streak<\/strong> is more about repetition than a one-off spike.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Fundamental_Analysis\"><\/span><strong>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,353.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 17.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 233.38<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) fundamental metrics show P\/E 68.76x, P\/B 5.04x, ROE 11.22%, ROCE 12.41%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD has a market capitalisation of Rs 7353.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 68.76x, P\/B at 5.04x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.22% and ROCE of 12.41%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.1, book value per share of Rs 233.38, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 27.95x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">68.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">41.62x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 688.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.63%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,353.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 765.11 crore<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 68.76x, which is above the benchmark median of 27.95x, a difference of +146.01%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROE of 11.22%, which is below the benchmark median of 11.74%, a difference of -4.43%. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a ROCE of 12.41%, which is below the benchmark median of 13.63%, a difference of -8.95%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_May_Be_Moving_Today\"><\/span><strong>Why SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) May Be Moving Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>According to recent news reports, <strong>SYMBIOTEC Stock News<\/strong> includes a partnership involving its subsidiary Knovea and a major global pharmaceutical company for US sales of two dual chamber vial products. That development may be linked to the renewed attention around <strong>SYMBIOTEC Share Price Today<\/strong>, as it points to a possible expansion in market reach and revenue streams. The news does not prove causation, but it coincides with the stock\u2019s <strong>SYMBIOTEC 52 Week High Streak<\/strong> and may help explain why the name remains among <strong>Stocks At One Year High Today<\/strong> and other <strong>Stocks In News Today<\/strong>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/innovacap\/innova-captab-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Innova Captab Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INNOVACAP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,282.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Bliss GVS Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BLISSGVS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,550<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanofi\/sanofi-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sanofi India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SANOFI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,072.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.46<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/supriya\/supriya-lifescience-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Supriya Lifescience Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUPRIYA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,652.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/morepenlab\/morepen-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Morepen Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MOREPENLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,509.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.19<\/td>\n<\/tr>\n<\/table>\n<p>SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a P\/E ratio of 68.76x compared with the displayed peer median of 42.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.22% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 12.41% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) has a market capitalisation of Rs 7,353.15 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC\"><\/span><strong>Why Investors Are Watching SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>SYMBIOTEC 52 Week High Streak<\/strong> has extended for a second straight session, keeping the stock near its one-year peak.<\/li>\n<li>The cumulative move across the streak stands at 3.72%, which is the key multi-session read for <strong>SYMBIOTEC Share Price<\/strong>.<\/li>\n<li><strong>SYMBIOTEC Fundamental Analysis<\/strong> shows a P\/E of 68.76 and a P\/B of 5.04, both above the industry median.<\/li>\n<li>The latest news item on Knovea\u2019s US sales partnership is the only specific development that may be linked to <strong>SYMBIOTEC Stock News<\/strong> flow today.<\/li>\n<li><strong>SYMBIOTEC Market Cap<\/strong> at Rs 7353.15 crore places the company well above the industry median market value.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC\"><\/span><strong>About SYMBIOTEC PHARMALAB LTD (SYMBIOTEC)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>SYMBIOTEC PHARMALAB LTD<\/strong> operates in the Healthcare sector within the Pharmaceuticals &amp; Drugs industry. The company\u2019s <strong>SYMBIOTEC Share Price<\/strong> is now being tracked closely because it has stayed near its 52-week high for a second straight session. Its latest market capitalisation is Rs 7353.15 crore, and the company is valued at a premium to the industry median on earnings and book metrics. For readers scanning <strong>SYMBIOTEC Company News<\/strong> and <strong>SYMBIOTEC Stock Performance<\/strong>, the current focus is on how long the stock can remain near its yearly peak.<\/p>\n<p>That makes <strong>SYMBIOTEC NSE<\/strong> and <strong>SYMBIOTEC BSE<\/strong> watchlists relevant for investors who follow pharma names with a sustained high-price pattern. The company also sits within a peer group that includes Innova Captab, Bliss GVS Pharma, Sanofi India, Supriya Lifescience and Morepen Laboratories. The latest <strong>SYMBIOTEC Stock Analysis<\/strong> therefore sits at the intersection of price behaviour, valuation and sector positioning.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_SYMBIOTEC_52_Week_High_Streak_mean\"><\/span><strong>What does the SYMBIOTEC 52 Week High Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means SYMBIOTEC has traded within 2% of its 52-week high for a second straight session. The pattern is useful because it shows the stock is staying near its yearly peak rather than only touching that zone once.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_SYMBIOTEC_traded_near_its_52-week_high\"><\/span><strong>How many sessions has SYMBIOTEC traded near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> According to latest Univest figures, the streak now covers two consecutive sessions. The stock has remained close to its 52-week high across both sessions, which is why the repeated-high pattern is being tracked.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_cumulative_move_in_the_SYMBIOTEC_52_Week_High_Streak\"><\/span><strong>What is the cumulative move in the SYMBIOTEC 52 Week High Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative move across the streak is 3.72%. That figure captures the multi-session price change and is more relevant here than the day-to-day move alone for understanding the repeated-high setup.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_SYMBIOTEC_at_a_new_all-time_high\"><\/span><strong>Is SYMBIOTEC at a new all-time high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The latest numbers confirm a 52-week high pattern, not an all-time high claim. The article should be read as a one-year high streak update, not as a lifetime record update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_latest_SYMBIOTEC_Share_Price_Today_levels\"><\/span><strong>What are the latest SYMBIOTEC Share Price Today levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SYMBIOTEC was trading at Rs 1186.95 after opening at Rs 1197.8 and moving between Rs 1159.85 and Rs 1222. The price remained near its yearly high zone during the period covered here.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SYMBIOTEC_compare_with_peers_on_valuation\"><\/span><strong>How does SYMBIOTEC compare with peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock trades at a P\/E of 68.76 and a P\/B of 5.04, which is above the industry median. Compared with peers such as Innova Captab, Bliss GVS Pharma and Supriya Lifescience, the valuation is on the richer side.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_fundamental_metrics_matter_most_for_SYMBIOTEC_Stock_Analysis\"><\/span><strong>What fundamental metrics matter most for SYMBIOTEC Stock Analysis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors usually look at P\/E, P\/B, ROE, ROCE, EPS, book value and market capitalisation. For SYMBIOTEC, the current mix shows a premium valuation alongside ROE of 11.22% and ROCE of 12.41%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_SYMBIOTEC_Stock_News\"><\/span><strong>What should investors monitor next in SYMBIOTEC Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may monitor whether the stock keeps trading near its 52-week high, whether any new company news appears, and whether the valuation remains supported by financial performance. The repeated-high pattern is the key item to watch.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What does the SYMBIOTEC 52 Week High Streak mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means SYMBIOTEC has traded within 2% of its 52-week high for a second straight session. The pattern is useful because it shows the stock is staying near its yearly peak rather than only touching that zone once.\"}},{\"@type\":\"Question\",\"name\":\"How many sessions has SYMBIOTEC traded near its 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"According to latest Univest figures, the streak now covers two consecutive sessions. The stock has remained close to its 52-week high across both sessions, which is why the repeated-high pattern is being tracked.\"}},{\"@type\":\"Question\",\"name\":\"What is the cumulative move in the SYMBIOTEC 52 Week High Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative move across the streak is 3.72%. That figure captures the multi-session price change and is more relevant here than the day-to-day move alone for understanding the repeated-high setup.\"}},{\"@type\":\"Question\",\"name\":\"Is SYMBIOTEC at a new all-time high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. The latest numbers confirm a 52-week high pattern, not an all-time high claim. The article should be read as a one-year high streak update, not as a lifetime record update.\"}},{\"@type\":\"Question\",\"name\":\"What are the latest SYMBIOTEC Share Price Today levels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SYMBIOTEC was trading at Rs 1186.95 after opening at Rs 1197.8 and moving between Rs 1159.85 and Rs 1222. The price remained near its yearly high zone during the period covered here.\"}},{\"@type\":\"Question\",\"name\":\"How does SYMBIOTEC compare with peers on valuation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock trades at a P\/E of 68.76 and a P\/B of 5.04, which is above the industry median. Compared with peers such as Innova Captab, Bliss GVS Pharma and Supriya Lifescience, the valuation is on the richer side.\"}},{\"@type\":\"Question\",\"name\":\"What fundamental metrics matter most for SYMBIOTEC Stock Analysis?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors usually look at P\/E, P\/B, ROE, ROCE, EPS, book value and market capitalisation. For SYMBIOTEC, the current mix shows a premium valuation alongside ROE of 11.22% and ROCE of 12.41%.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next in SYMBIOTEC Stock News?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors may monitor whether the stock keeps trading near its 52-week high, whether any new company news appears, and whether the valuation remains supported by financial performance. The repeated-high pattern is the key item to watch.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_SYMBIOTEC_PHARMALAB_LTD_SYMBIOTEC_Share_Price_on_Univest\"><\/span><strong>Track SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/symbiotec\/symbiotec-pharmalab-ltd-share-price-today\">SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SYMBIOTEC PHARMALAB LTD Share Price trades near its 52-week high at Rs 1,186.95, marking a 0.93% rise today. Market cap stands at Rs 7,353.15 crore.<\/p>\n","protected":false},"author":38,"featured_media":282645,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-282646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["282645"],"rank_math_title":["SYMBIOTEC 52 Week High Streak: Consecutive High Analysis"],"rank_math_description":["SYMBIOTEC has traded near its 52-week high for a second straight session, with a 3.72% streak gain, valuation context and sector comparison."],"rank_math_focus_keyword":["SYMBIOTEC 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/symbiotec-pharmalab-ltd-symbiotec-symbiotec-52-week-high-streak-consecutive-high.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=282646"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282646\/revisions"}],"predecessor-version":[{"id":282648,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282646\/revisions\/282648"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/282645"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=282646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=282646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=282646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}